W. Mark Watson is Director of Vaxart, Inc.. Currently has a direct ownership of 78,125 shares of VXRT, which is worth approximately $48,437. The most recent transaction as insider was on Jun 18, 2024, when has been sold 20,000 shares (Common Stock) at a price of $0.68 per share, resulting in proceeds of $13,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 78.1K
0% 3M change
85.46% 12M change
Total Value Held $48,437

W. Mark Watson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 18 2024
BUY
Open market or private purchase
$13,600 $0.68 p/Share
20,000 Added 20.38%
78,125 Common Stock
Jun 11 2024
BUY
Grant, award, or other acquisition
-
16,000 Added 21.59%
58,125 Common Stock
Jun 26 2023
BUY
Grant, award, or other acquisition
-
7,375 Added 14.9%
42,125 Common Stock
Dec 28 2022
BUY
Open market or private purchase
$15,200 $0.76 p/Share
20,000 Added 50.0%
20,000 Common Stock
Aug 04 2022
BUY
Grant, award, or other acquisition
-
14,750 Added 50.0%
14,750 Common Stock

Also insider at

INTI
Inhibitor Therapeutics, Inc. Healthcare
BDSI
BIODELIVERY SCIENCES INTERNATIONAL INC Healthcare
WMW

W. Mark Watson

Director
South San Francisco, CA

Track Institutional and Insider Activities on VXRT

Follow Vaxart, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VXRT shares.

Notify only if

Insider Trading

Get notified when an Vaxart, Inc. insider buys or sells VXRT shares.

Notify only if

News

Receive news related to Vaxart, Inc.

Track Activities on VXRT